Citable company snapshot
CVS Health's latest SEC-sourced 2026-06-30 period shows $106.10B in revenue and $2.98B in net income.
| Metric | Latest period | Latest value | Prior value | YoY |
|---|---|---|---|---|
| Revenue | Jun 30, 2026 | $106.10B | $100.43B | +5.6% |
| Gross Profit | Sep 30, 2018 | $7.33B | $7.20B | +1.8% |
| Operating Income | Jun 30, 2026 | $4.70B | $4.68B | +0.5% |
| Net Income | Jun 30, 2026 | $2.98B | $2.94B | +1.2% |
| Operating Cash Flow (computed) | Jun 30, 2026 | $6.34B | $4.25B | +49.3% |
| Free Cash Flow (computed) | Jun 30, 2026 | $5.65B | $3.40B | +66.3% |
Source: SEC EDGAR financial statements; period Jun 30, 2026; filed Aug 5, 2026; accession 0000064803-26-000098.
CVS company research is available with Aerarium Pro (CAD $10/mo). The five showcase tickers (TSLA, NVDA, AAPL, AMZN, PLTR) and the macro dashboard stay free. Already a subscriber? Sign in to pick up where you left off.